(Q41114391)

26 September 2017

Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1551637

8 October 2022

1 reference

U. Beuers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1551637

8 October 2022

U. Spengler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1551637

8 October 2022

F. M. Zwiebel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1551637

8 October 2022

J. Pauletzki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1551637

8 October 2022

S. Fischer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1551637

8 October 2022

G. Paumgartner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1551637

8 October 2022

language of work or name

English

0 references

publication date

1 April 1992

1 reference

26 September 2017

1 reference

26 September 2017

15

1 reference

26 September 2017

4

1 reference

26 September 2017

603-608

1 reference

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

26 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

No decrease in duodenal ulcer surgery after cimetidine in Hong Kong.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Current concepts. Primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Simultaneous determination of pool sizes and fractional turnover rates, of deoxycholic acid, cholic acid and chenodeoxycholic acid in man by isotope dilution with 2H and 13C labels and serum sampling

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Effects of cholecystectomy on the kinetics of primary and secondary bile acids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane bonded silica cartridges

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Synthesis of the specific monosulfates of cholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

A modified gas-liquid chromatographic procedure for the rapid determination of bile acids in biological fluids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Serum bile acid analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Quantitative estimation of bile salts in serum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Bile acid inhibition of intestinal anaerobic organisms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Regulation of bile acid synthesis. II. Effect of bile acid feeding on enzymes regulating hepatic cholesterol and bile acid synthesis in the rat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Serum bile acids. Physiological determinants and results in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

The turnover of cholic acid in man: bile acids and steroids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Tauroursodeoxycholic acid inhibits the cytosolic Ca++ increase in human neutrophils stimulated by formyl-methionyl-leucyl-phenylalanine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150409

7 January 2021

Identifiers

DOI

10.1002/HEP.1840150409

1 reference

26 September 2017

1 reference